Funds from NIH will advance ALX1 as a potential treatment in Cystic Fibrosis and other chronic lung diseases MORRISVILLE, N.C., Jan. 21, 2025 /PRNewswire/ — Vast Therapeutics, a clinical-stage life science company, today announced that it has been awarded a nearly two million dollar…
Vast Awarded $2 Million Grant to Combat Deadly Respiratory Bacteria
Funds from NIH will advance ALX1 as a potential treatment in Cystic Fibrosis and other chronic lung diseases MORRISVILLE, N.C., Jan. 21, 2025 /PRNewswire/ — Vast Therapeutics, a clinical-stage life science company, today announced that it has been awarded a nearly two million dollar…
